Business / Finance

RSS

3M announces acquisition of Zargis Medical assets

3M announced today it has acquired certain assets of Zargis Medical Corp., maker of the only FDA-approved diagnostic software to classify suspected systolic and diastolic heart murmurs.

1 Apr 2011

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software, Inc. announced today its financial results, reporting annual revenue in 2010 decreased approximately 5% to $3.48 million compared to $3.66 million in 2009.

1 Apr 2011

UHS acquires Emergent Group and PRI Medical

Universal Hospital Services, Inc., a leading provider of medical equipment management and service solutions, today announced the completion of its acquisition of Emergent Group Inc. and its wholly owned subsidiary, PRI Medical Technologies, Inc., a leading provider of mobile medical lasers and surgical equipment.

1 Apr 2011

Microbix closes private financing for $0.35 per share

Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, today announced the closing of the first tranche of a private placement resulting in the issue of 400,000 Units at a price of $0.35 per Unit.

1 Apr 2011

Baylor, Select announce closing of joint venture transaction

Baylor Health Care System and Select Medical Corporation today announced that they have closed their previously announced joint venture transaction, and that the joint venture will commence operations on April 1, 2011.

1 Apr 2011

Angiotech files Second Amended and Restated CCAA Plan of Compromise or Arrangement

Angiotech Pharmaceuticals, Inc. today announced that in connection with its previously announced creditor protection proceedings under the Companies' Creditors Arrangement Act (Canada), it and certain of its subsidiaries filed with the Supreme Court of British Columbia the Second Amended and Restated CCAA Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities.

1 Apr 2011

Blue Cross and Blue Shield of Minnesota reports $9 billion revenue for 2010

Blue Cross and Blue Shield of Minnesota and its family of companies (Blue Cross) today announced audited financial results for 2010. The nonprofit health company reported full-year 2010 revenues of $9 billion and an operating margin of 1.4%, which resulted in a net operating income of $127 million. This marks the second consecutive year of positive operating results, following three consecutive years of operating losses from 2006 to 2008.

1 Apr 2011

Akela reports net income of $1.5 million for three months ended December 31, 2010

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.

1 Apr 2011

China BCT fourth quarter revenue increases 82.3% to $66.8 million

China BCT Pharmacy Group, Inc.,, a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the fourth quarter and full year ended December 31, 2010.

31 Mar 2011

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its fourth quarter and full year financial results periods ended December 31, 2010.

31 Mar 2011

Protox reports net loss of $4.5 million for year ended December 31, 2010

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the year ended December 31, 2010.

31 Mar 2011

PSTX closes common stock financing for $7.1 million

Patient Safety Technologies, Inc. today announced the closing of a $7.1 million common stock financing. The investors, led by a new institutional investor, together with several existing shareholders and certain members of senior management, purchased 9.48 million shares of common stock at a price of $0.75 per share.

31 Mar 2011

RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera.

31 Mar 2011

Adeona reports $3,164,512 net revenue for 2010

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, reported its financial results for the year ended December 31, 2010, as well as updates since the beginning of the 4th quarter.

31 Mar 2011

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL and established 2011 financial guidance.

31 Mar 2011